Yinlei Bai

机构：Annoroad Gene Technology (China) · ORCID：0000-0002-8724-7334

发表论文 17 篇 · 总被引 220 次 · h-index 8

代表论文

• Molecular detection of minimal residual disease in multiple myeloma (2017 · British Journal of Haematology · 被引 47)
• Polyketides with New Delhi Metallo-β-lactamase 1 Inhibitory Activity from Penicillium sp. (2013 · Journal of Natural Products · 被引 41)
• Proteomic Changes of Klebsiella pneumoniae in Response to Colistin Treatment and crrB Mutation-Mediated Colistin Resistance (2020 · Antimicrobial Agents and Chemotherapy · 被引 40)
• High applicability of ASO-RQPCR for detection of minimal residual disease in multiple myeloma by entirely patient-specific primers/probes (2016 · Journal of Hematology & Oncology · 被引 24)
• Integrated analysis of circulating tumour cells and circulating tumour DNA to detect minimal residual disease in hepatocellular carcinoma (2022 · Clinical and Translational Medicine · 被引 20)
• Molecular diagnosis of pancreatobiliary tract cancer by detecting mutations and methylation changes in bile samples (2022 · EClinicalMedicine · 被引 16)